DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

NCT07011095 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation (AF)
Stroke (in Patients With Atrial Fibrillation)

Interventions

DRUG: VKA
DRUG: Direct Oral Anticoagulant (DOAC)

Sponsor

Population Health Research Institute